CAT No: CP25199
CAS No:118554-00-0
Synonyms/Alias:Boc-Orn(2-Cl-Z)-OH;118554-00-0;ST51036373;Nalpha-Boc-Ndelta-(2-chloro-Z)-L-ornithine;AC1OJJ2A;C18H25ClN2O6;15537_ALDRICH;15537_FLUKA;MolPort-003-926-841;ZINC4521273;CB-353;FC1233;MFCD00076972;AKOS015924219;AKOS016003084;AJ-51391;AK-81139;KB-92555;N|A-Boc-N|A-(2-chloro-Z)-L-ornithine;FT-0642900;ST24030212;N(alpha)-boc-N(delta)-(2-chloro-Z)-L-ornithine;(2S)-2-[(tert-butoxy)carbonylamino]-5-{[(2-chlorophenyl)methoxy]carbonylamino}pentanoicacid;(2S)-5-[(2-chlorophenyl)methoxycarbonylamino]-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoicacid
Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-delta-(2-chloro-benzyloxycarbonyl)-L-ornithine
1. Implications of ligand-receptor binding kinetics on GLP-1R signalling
3. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.